Khargone, India

Ravish Sharma

USPTO Granted Patents = 5 

Average Co-Inventor Count = 9.7

ph-index = 3

Forward Citations = 23(Granted Patents)


Company Filing History:


Years Active: 2015-2017

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Ravish Sharma: Innovator in Pharmaceutical Formulations

Introduction

Ravish Sharma is a notable inventor based in Khargone, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug formulations. With a total of five patents to his name, Sharma's work has the potential to enhance treatment options for various medical conditions.

Latest Patents

Sharma's latest patents include a pharmaceutical gastro-retentive solid oral dosage form of nilotinib. This invention relates to a dosage form that comprises nilotinib as the active ingredient, along with methods for preparing it. Another significant patent is for a pharmaceutical composition of doxycycline with a reduced food effect. This once-daily composition includes doxycycline and one or more pharmaceutically acceptable excipients, designed to exhibit a reduced food effect. The invention also provides a method for treating rosacea by administering the doxycycline composition with or without food.

Career Highlights

Throughout his career, Ravish Sharma has worked with prominent companies in the pharmaceutical industry. He has been associated with Sun Pharmaceutical Industries Limited and Ranbaxy Laboratories, Inc. His experience in these organizations has contributed to his expertise in pharmaceutical innovations.

Collaborations

Sharma has collaborated with several professionals in his field, including Anuj Kumar Fanda and Romi Barat Singh. These collaborations have likely enriched his research and development efforts.

Conclusion

Ravish Sharma's contributions to pharmaceutical formulations demonstrate his commitment to advancing medical science. His innovative patents reflect his expertise and dedication to improving patient care through effective drug delivery systems.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…